Group One Trading, L.P. Mei Pharma, Inc. Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.21 - $0.35 $3,190 - $5,317	-15,192 Reduced 99.66%	52 $0
Q4 2022 Feb 09, 2023	SELL	$0.22 - $8.4 $46,397 - $1.77 Million	-210,898 Reduced 93.26%	15,244 $3,000
Q3 2022 Nov 09, 2022	BUY	$0.41 - $8.8 $12,756 - $273,803	31,114 Added 15.95%	226,142 $87,000
Q2 2022 Aug 11, 2022	BUY	$0.42 - $0.65 $81,911 - $126,768	195,028 New	195,028 $118,000
Q4 2021 Feb 11, 2022	SELL	$2.33 - $3.37 $12,642 - $18,285	-5,426 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.52 - $2.99 $13,673 - $16,223	5,426 New	5,426 $15,000
Q1 2018 May 11, 2018	SELL	$2.06 - $2.38 $16,010 - $18,497	-7,772 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$1.91 - $2.83 $4,492 - $6,656	2,352 Added 43.39%	7,772 $16,000
Q3 2017 Nov 15, 2017	BUY	$2.44 - $2.91 $13,224 - $15,772	5,420	5,420 $15,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.